Enlon

Active Ingredient(s): Edrophonium
FDA Approved: * August 6, 1985
Pharm Company: * BAXTER HLTHCARE CORP
Category: Myasthenic Syndrome

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Enlon Overview

Edrophonium is a readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction. It is sold under the trade names Tensilon and Enlon (according to FDA Orange Book). Contents 1 Clinical uses 2 Chemistry 3 Pharmacokinetics 4 References 5 Further reading Clinical uses Edrophonium (by the so-called Tensilon test) is used to differentiate...

Read more Enlon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Edrophonium

Recent Enlon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Enlon: (1 result)

Sorted by National Drug Code

• 67457-190 Enlon 10 mg/ml Intramuscular; Intravenous Injection, Solution by Mylan Institutional LLC

Other drugs which contain Edrophonium or a similar ingredient: (5 results)

• EDROPHONIUM
• REVERSOL Edrophonium
• TENSILON Edrophonium
• ATROPINE + EDROPHONIUM
• ENLON PLUS Atropine + Edrophonium